Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Colorcon
AstraZeneca
Boehringer Ingelheim
Harvard Business School
Medtronic
Merck

Last Updated: December 12, 2019

DrugPatentWatch Database Preview

Iron dextran - Generic Drug Details

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What are the generic sources for iron dextran and what is the scope of patent protection?

Iron dextran is the generic ingredient in four branded drugs marketed by Luitpold, Allergan Sales Llc, Sanofi Aventis Us, and New River, and is included in four NDAs. Additional information is available in the individual branded drug profile pages.

There are eighty-two drug master file entries for iron dextran. Four suppliers are listed for this compound.

Summary for iron dextran
Recent Clinical Trials for iron dextran

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Orthopedic Research and Education FoundationPhase 1
Hospital for Special Surgery, New YorkPhase 1
West China HospitalN/A

See all iron dextran clinical trials

Pharmacology for iron dextran
Synonyms for iron dextran
10124-49-9
9004-66-4
AC1L2XZQ
AC1LAX7G
AKOS030243004
Conferon
CTK8G0362
EINECS 233-336-3
FeH2O4S
Fero Gradumet
FT-0624534
Iron-Dextran
iron; sulfuric acid
K629
KS-00000XZM
NSC-146177
NSC-57631
NSC146177
NSC57631
Sulfuric acid iron salt (1:1)
Sulfuric acid iron(2+) salt (1:1)
Sulfuric acid, iron salt
Sulfuric acid, iron salt (1:?)
Sulphuric acid, iron salt
WLN: FE S-O4

US Patents and Regulatory Information for iron dextran

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Allergan Sales Llc INFED iron dextran INJECTABLE;INJECTION 017441-001 Approved Prior to Jan 1, 1982 BP RX Yes Yes   Start Trial   Start Trial   Start Trial
Sanofi Aventis Us IRON DEXTRAN iron dextran INJECTABLE;INJECTION 010787-002 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Luitpold DEXFERRUM iron dextran INJECTABLE;INJECTION 040024-001 Feb 23, 1996 DISCN No No   Start Trial   Start Trial   Start Trial
New River PROFERDEX iron dextran INJECTABLE;INJECTION 017807-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Express Scripts
Mallinckrodt
Merck
McKinsey
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.